Download PDF
Thromb Haemost 1993; 70(01): 010-016
DOI: 10.1055/s-0038-1646152
Plenary Lecture
Schattauer GmbH Stuttgart

Vascular Smooth Muscle Cell Proliferation: Basic Investigations and New Therapeutic Approaches

Robert D Rosenberg
Beth Israel Hospital and Harvard Medical School, Boston, MA, USA
Massachusetts Institute of Technology, Cambridge, MA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dilley RJ, McGcachie JK, Prendergast FJ. A review of proliferative behavior, morphology and phenotypes of vascular smooth muscle. Atherosclerosis 1987; 63: 99-107
    CrossrefPubMedGoogle Scholar
  • 2 Libby P, Warner SJC, Solomon RN, Birinyi LK. Production of platelet-derived growth factor-like mitogen by smooth muscle cells from atheroma. N Engl.J Med 1988; 318: 1493-1498
    CrossrefPubMedGoogle Scholar
  • 3 Kuro-o M, Nagai R, Tsuchimoci H, Katoh H, Yazaki Y, Ohkubo A, Takaku F. Developmentally regulated expression of vascular smooth muscle myosin heavv chain isoforms. J Biol Chem 1989; 264: 18272-18275
    PubMedGoogle Scholar
  • 4 Clowes AW, Clowes MM, Kocher O, Ropraz P, Chaponnier C, Gabbiani G. Arterial smooth muscle cells in vivo: Relationship between actin isoform expression and mitogenesis and their regulation by heparin. J Cell Biol 1988; 107: 1939-1945
    CrossrefPubMedGoogle Scholar
  • 5 Ross R, Raines EW, Bowen-Popc DF. The biology of platelet-derived growth factor. Cell 1986; 46: 155-169
    CrossrefPubMedGoogle Scholar
  • 6 Banscota NK, Taub R, Zellner K, King GL. Insulin, insulin-like growth factor I and platelet derived growth factor interact additively in the induction of the proto oncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 1989; 3: 1183-1190
    CrossrefPubMedGoogle Scholar
  • 7 Libby P, Warner SJC, Friedman GB. Interleukin I: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988; 81: 487-498
    CrossrefPubMedGoogle Scholar
  • 8 Gay CG, Winkles JA. Interleukin I regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1991; 88: 296-300
    CrossrefPubMedGoogle Scholar
  • 9 Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol 1987; 105: 465-471
    CrossrefPubMedGoogle Scholar
  • 10 Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739-3743
    CrossrefPubMedGoogle Scholar
  • 11 Kindy MS, Sonenshcin GE. Regulation of oncogene expression in cultured aortic smooth muscle celts. J Biol Chem 1986; 261: 12865-12868
    PubMedGoogle Scholar
  • 12 Kawamoto S, Adelstein RS. Characterization of myosin heavy chains in cultured aorta smooth muscle cells. J Biol Chem 1987; 262: 7282-7288
    PubMedGoogle Scholar
  • 13 Toulme JJ, Helene C. Anlimessenger oligodeoxyribonucleotidcs: an alternative to antisense RNA for artificial regulation of gene expression—a review. Gene 1988; 72: 51-58
    CrossrefPubMedGoogle Scholar
  • 14 Thompson CB, Challoner PB, Neiman PE, Groudine M. Expression of the c-myb proto-oncogene during cellular proliferation. Nature 1986; 319: 374-380
    CrossrefPubMedGoogle Scholar
  • 15 Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonenshein GE. Heparin prevents vascular smooth muscle cell progression through the Gl phase of the cell cycle. J Biol Chem 1989; 264: 6990-6995
    PubMedGoogle Scholar
  • 16 Travali S, Ferber A, Reiss K, Sell C, Koniecki J, Calabretta B, Baserga R. Effect of the myb gene product on the expression of the PCN A gene in fibroblasts. Oncogene 1991; 6: 887-894
    PubMedGoogle Scholar
  • 17 Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265: 625-626
    CrossrefPubMedGoogle Scholar
  • 18 Reilly CF, Fritze LMS, Rosenberg RD. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor. J Cell Physiol 1986; 131: 149-157
    PubMedGoogle Scholar
  • 19 Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ. Inhibition of rat arterial smooth muscle proliferation by heparin. Circ Res 1980; 46: 625-634
    CrossrefPubMedGoogle Scholar
  • 20 Fritze LMS, Reilly CF, Rosenberg RD. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J Cell Biol 1985; 100: 1041-1049
    CrossrefPubMedGoogle Scholar
  • 21 Simons M, Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 1992; 70: 835-843
    CrossrefPubMedGoogle Scholar
  • 22 Simons M, Morgan KG, Parker C, Collins E, Rosenberg RD. The proto-oncogene c-myb mediates an intracellular calcium rise during the late Gl phase of the cell cycle. J Biol Chem 1993; 268: 627-632
    PubMedGoogle Scholar
  • 23 Keith CH, Ratan R, Maxfield FR, Bajer A, Shelanski Z. Local cytoplasmic calcium gradients in living mitotic cells. Nature 1985; 316: 848-850
    CrossrefPubMedGoogle Scholar
  • 24 Poenie M, Alderton J, Steinhardt R, Tsien R. Calcium rises abruptly and briefly throughout the cell at the onset of anaphase. Science 1986; 233: 886-889
    CrossrefPubMedGoogle Scholar
  • 25 Steinhardt RA, Alderton J. Intracellular free calcium rise triggers nuclear envelope breakdown in the sea urchin embryo. Nature 1988; 332: 364-366
    CrossrefPubMedGoogle Scholar
  • 26 Twigg J, Patel R, Whitaker M. Translational control of InsP3-induced chromatin condensation during the early cell cycles of sea urchin embryos. Nature 1988; 332: 366-369
    CrossrefPubMedGoogle Scholar
  • 27 Sisken JE, Silver RB, Barrows GH, Grasch SD. Studies on the role of Ca++ in cell division with the use of fluorescent probes and quantitative video intensification microscopy. In: Advances in Microscopy. Cowden RR, Harrison FW. (eds) Alan R Liss; New York: 1985. pp. 73-87
    Google Scholar
  • 28 Mcintosh JR, Koonce MP. Mitosis. Science 1989; 246: 622-628
    CrossrefPubMedGoogle Scholar
  • 29 Paul D, Ristom HJJ. Cell cycle control bv Ca++ ions in mouse 3T3 cells and in transformed 3T3 cells. J Cell Physiol 1979; 98: 31-40
    CrossrefPubMedGoogle Scholar
  • 30 Pardee AB, Dubrow R, Hamlin JL, Kletzien RF. Animal cell cycle. Ann Rev Biochem 1978; 47: 715-750
    CrossrefPubMedGoogle Scholar
  • 31 Luscher B, Eisenman RN. New light on Myc and Myb. Part II. Myb. Genes Dev 1990; 4: 2235-2241
    CrossrefPubMedGoogle Scholar
  • 32 Evans JL, Moore TL, Kuehl WM, Bender T, Ting JP. Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it transactivates the c-Myc promoter. Mol Cell Biol 1990; 10: 5747-5752
    CrossrefPubMedGoogle Scholar
  • 33 Dudek H, Tantravahiv RV, Rao VN, Reddy ES, Reddy EP. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc Natl Acad Sci USA 1992; 89: 1291-1295
    CrossrefPubMedGoogle Scholar
  • 34 Iida H, Sakaguchi S, Yagawa Y, Anraku Y. Cell cycle control by Ca2+ in Saccharomyees cerevisiae . J Biol Chem 1990; 265: 21216-21222
    PubMedGoogle Scholar
  • 35 Chafouleas JG, Bolton WE, Hidaka H, Boyd III AE, Means AR. Calmodulin and the cell cycle: Involvement in regulation of celt-cycle progression. Cell 1982; 28: 41-50
    CrossrefPubMedGoogle Scholar
  • 36 Rasmussen CD, Means AR. Calmodulin is required for cell-cycle progression during G1 and mitosis. EMBO J 1989; 8: 73-82
    PubMedGoogle Scholar
  • 37 Simons M, Edelman ER, DeKeyser JL, Langer RS, Rosenberg RD. Antisense c-myb oligonucleotides suppress smooth muscle accumulation in vivo. Nature 1992; 359: 67-70
    CrossrefPubMedGoogle Scholar
  • 38 Deuel TF, Huang JS. Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells. J Clin Invest 1984; 74: 669-676
    CrossrefPubMedGoogle Scholar
  • 39 Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-113
    CrossrefPubMedGoogle Scholar
  • 40 Jawien A, Bowcn-Pope DF, Lindner V, Schwartz SM, Clowes AM. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992; 89: 507-511
    CrossrefPubMedGoogle Scholar
  • 41 Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. Alpha-interferon regulates vascular smooth muscle proliferation and la antigen expression in vivo and in vitro. Circ Res 1988; 63:: 712-719
    CrossrefPubMedGoogle Scholar
  • 42 Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neoinlimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-1132
    CrossrefPubMedGoogle Scholar
  • 43 Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasa-ki N, Yokoi H, Kim KJ. Restenosis after percutaneous transluminal coronary angioplasty: Pathology observations in twenty patients. Am Coll Cardiol 1991; 17: 433-439
    CrossrefPubMedGoogle Scholar
  • 44 Jonasson L, Holm J, Hannson GK. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci USA 1988; 85: 2303-2306
    CrossrefPubMedGoogle Scholar
  • 45 Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-188
    CrossrefPubMedGoogle Scholar
  • 46 Pukac LA, Hirsch GM, Lormeau JC, Petitou M, Choay J, Karnovsky M. Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cell in vitro and in vivo. Am J Pathol 1991; 139: 1501-1509
    PubMedGoogle Scholar